1.Cloning and expression of extracellular region gene located in N-terminus of Leishmania Donovani.
Xian CHEN ; Jianping CHEN ; Jia'nan XU ; Xin WANG ; Rui LU ; Dianxiang LU ; Xiaosu HO
Journal of Biomedical Engineering 2009;26(4):820-824
The objective of this study was to construct and express recombinant prokaryotic plasmid pET32a (+)- ast1 in E. coli BL21(DE3). Amastin gene was amplified from genomic DNA of Leishmania Donovani and its transmembran region was predicted by the methods of SOSUI and Tmpred; astl located in N-terminus of amastin gene was amplified and cloned into prokaryotic plasmid pET32a(+), which was named pET32a(+)-ast1, and then rAST1 was expressed in E. coli BL21(DE3). The results of SDS-PAGE and immunobloting assay showed that a fusion protein rAST1 (relative molecular mass about 27 kDa) was able to express in BL21. The recombinant prokaryotic plasmid pET32a(+)- ast1 was successfully constructed, and noted to be efficiently expressed in E. coli BL21(DE3).
Animals
;
Cloning, Molecular
;
Escherichia coli
;
genetics
;
metabolism
;
Extracellular Space
;
Genes, Protozoan
;
Leishmania donovani
;
genetics
;
Plasmids
;
genetics
;
Protozoan Proteins
;
biosynthesis
;
genetics
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
2.Cloning the lvgA gene of Legionella pneumophila and detecting its expression in Escherichia coli.
Mingjie LIU ; Jianping CHEN ; Tao LIAO ; Dianxiang LU ; Xian CHEN
Journal of Biomedical Engineering 2006;23(3):605-608
In order to clone lvgA gene (Legionella virulence gene) of Legionella pneumophila and detect its expression in prokaryotic cell, we amplified the lvgA gene from the total cell DNA of Legionella pneumophila with PCR,and then inserted it into the coloning vector pUC18. The recombinant plasmid pUlvgA was obtained. After the recombinant plasmid pUlvgA was identified with restriction enzyme analysis, polymerase chain reaction and nucleotide sequencing analysis, the lvgA gene was subcloned into the prokaryotic expression vector pGEX-4T-1. The prokaryotic expression recombinant plasmid pGlvgA was constructed. After IPTG induction, the E. coli JM109 containing the recombinant plasmid pGlvgA expressed fusion protein. The expression of lvgA was subsequently detected by SDS-polyacrylamine gel electrophoresis and Western-blot analysis. The results indicated that the lvgA gene of 627 bp long was amplified, the recombinant plasmids pUlvgA and pGlvgA were constructed successfully, and the GST-LvgA fusion protein of approximately 36 KDa in size was expressed in prokaryotic cell efficiently as expected.
Bacterial Proteins
;
genetics
;
metabolism
;
Cloning, Molecular
;
Cytoplasm
;
metabolism
;
Escherichia coli
;
metabolism
;
Legionella pneumophila
;
genetics
;
Prokaryotic Cells
;
metabolism
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
Virulence Factors
;
biosynthesis
;
genetics
3.Advances of Interleukin-6 in Pulmonary Hypertension
Tingting CHEN ; Jin YANG ; Dianxiang LU
Chinese Journal of Modern Applied Pharmacy 2024;41(10):1438-1446
Interleukin-6(IL-6) is a pleiotropic cytokine, which plays an important role in the inflammatory response. There is increasing evidence that IL-6 also plays a very important role in the development of pulmonary hypertension, as evidenced by the fact that circulating levels of IL-6 are significantly elevated in pulmonary hypertension patients and animal models, that overexpression of IL-6 in mice can induce severe pulmonary hypertension, and that treatment targeting IL-6 can improve pulmonary hypertension. This paper reviews the research progress on the role of IL-6 in pulmonary hypertension and its mechanism at the molecular level, and introduce the current candidate regimens targeting IL-6 for the treatment of pulmonary hypertension, in order to provide a reference for clinical drug research and development for pulmonary hypertension.
4.Electrothermal acupuncture in the prevention and treatment of chemotherapy-induced nausea and vomiting:a randomized controlled trial.
Dianrong LU ; Dianxiang LU ; Dapeng BAI ; Shengqi HE ; Fang WANG ; Yin GAO ; Yanlin DU ; Ningjun WANG ; Zhenglong JIANG ; Zemin WANG ; Shijie ZHU
Chinese Acupuncture & Moxibustion 2017;37(4):355-359
OBJECTIVETo observe the effectiveness and safety of electrothermal acupuncture in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV) in the cancerous patients of phlegm-stasis interaction in cisplatin-containing chemotherapy.
METHODSSixty cases of phlegm-stasis interaction in cisplatin-containing chemotherapy were randomized into a trial group and a control group, 30 cases in each one. In the control group, the intravenous drip of granisetron hydrochloride injection was adopted, 3 mg before and after cisplatin-containing chemotherapy 30 min, continuously for 3 days. 43 to 45℃ electrothermal acupuncture at zusanli(ST 36) for 30 min was used on the basis of the treatment as the control group in the trial group,once a day for 3 days. CINV, anti-nausea effects, Karnofsky score, the syndrome score of phlegm-stasis interaction, and relevant indices of safety were observed on the 1st and 7th days of cisplatin-containing chemotherapy separately.
RESULTS1.Regarding CINV and anti-nausea effect, CINV did not occur before chemotherapy in the patients of the two groups. On the 1st and 7th days of chemotherapy, CINV in the trial group were milder than those in the control group (both<0.05).The anti-nausea effects in the trail group were better than those of the control group.2.Regarding Karnofsky score and the syndrome score of phlegm-stasis interaction, the improvements on the 7th days of chemotherapy in the trial group were better than those in the control group, indicating the significant differences (both<0.05). 3.Regarding the safety indies, there was no adverse reaction during the treatment in the two groups.
CONCLUSIONSThe electrothermal acupuncture effectively relieves CINV, and improves self-care dbility and the symptoms of phlegm-stasis interaction.